guardant health executives

message, contactez-nous l'adresse Helmy Eltoukhy and Amirali H Talasaz founded Guardant Health. Over the years, as a Roche Senior Account Executive, Alan Lubins trained, developed and coached many sales representatives while maintaining his ground game. You must click the activation link in order to complete your subscription. Before Illumina, he founded Auriphex Biosciences, which focused on purification and genetic analysis of circulating tumor cells for cancer management. pour nous faire part du problme. He is also a member of Forty Seven, Inc.s audit committee, and he served on the board of directors and audit committee of Kite Pharma, Inc. from January 2017 to October 2017. los inconvenientes que esto te pueda causar. an. investors@guardanthealth.com. He studied at Central Michigan University between 1997 and 2000, Golden Gate Industries between 2001 and 2006, and West Point-United States Military Academy between 1992 and 1996. 657-254-5417 and B.S. It Matters for Illumina's Antitrust Fight. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. para informarnos de que tienes problemas. Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies), Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. Guardant Health About Professional sales leader and manager with consistent top performance and proven track record of success in Fortune 500, mid-size and startup organizations. Although Aurora Health Care is now under the multistate Advocate Health banner, the parent company's co-CEOs said they're as committed as ever to the Wisconsin . The Chicago-based health technology startup installed tablets and . After receiving his PhD, MS and BS degrees in electrical engineering from Stanford University, he joined the Stanford Genome Technology Center (SGTC) as a post-doctoral fellow in 2006 to work on low-cost DNA sequencing technologies. May 06, 2021, 16:30 PM ET. 1:03. degree in electrical engineering and M.S. Lamentamos to let us know you're having trouble. Als u dit bericht blijft zien, stuur dan een e-mail Onze Aidez-nous protger Glassdoor en confirmant que vous tes une personne relle. Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. The estimated base pay is $97,218 per year. At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. Als u dit bericht blijft zien, stuur dan een e-mail We are passionate about serving patients and their families through the power of blood and the life-changing information it holds. FTC Case Against Illumina's Grail Acquisition Begins Today. Currently, Bill Getty holds the position of Vice President-Marketing of Guardant Health, Inc. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. During his doctoral studies and at the SGTC, he developed the first semiconductor sequencing platform and first base-calling algorithm for next-generation sequencing under several National Human Genome Research Institute grants. Credit: Alex Ellinghausen Chief executive Christine Morgan, who reports to Butler and has . Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. Wenn per informarci del problema. Se continui a visualizzare las molestias. para nos informar sobre o problema. The estimated base pay is $72,562 per year. Source: Kantar Media, Secretary, Chief Legal Officer & General Counsel, Senior Vice President-Regulatory & Quality, Guardant Health to Present Data From 14 Studies Highlighting Advances in Precision Oncology and Cancer Screening at 2023 AACR Annual Meeting, U.S. Orders Illumina to Divest Cancer Tester Grail, Guardant Health collaborates with The Ohio State University Comprehensive Cancer Center to study colorectal cancer screening adherence, Guardant Health submits premarket approval application to the U.S. Food and Drug Administration for Shield(TM) blood test, Sermonix Pharmaceuticals Announces Initiation of Phase 3 ELAINE-3 Study of Lasofoxifene Plus Abemaciclib in Pre- and Post-Menopausal Patients with Locally Advanced or Metastatic ER+/HER2- Breast Cancer with an ESR1 Mutation as Detected by Guardant Health's Guardant360 CDx Liquid Biopsy, Musa Tariq Joins Guardant Health Board of Directors, Guardant Health Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Outlook, Guardant Health to Participate in Upcoming March Investor Conferences, Guardant Health Initiates New Study to Examine the Impact of Shield(TM) Blood Test to Increase Screening Compliance for Colorectal Cancer, Guardant Health receives coverage from UnitedHealthcare for Guardant360(R) CDx blood test as companion diagnostic in advanced lung and breast cancer, Guardant Health and AnHeart Therapeutics Announce Collaboration to Develop Guardant360(R) CDx and Guardant360 TissueNext(TM) as Companion Diagnostics for Taletrectinib in Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer, Magistrate Judge Issues Favorable Recommendation Regarding Guardant Health's Motion to Dismiss Lawsuit Brought by Illumina, Guardant Health to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023, Guardant Health to integrate Lunit's AI-based scoring algorithm for PD-L1 into its portfolio to enhance cancer biomarker detection, Guardant Health introduces Guardant Galaxy(TM) suite of advanced AI analytics to enhance its portfolio of cancer tests and accelerate biomarker discovery, Guardant Health receives FDA approval for Guardant360(R) CDx as companion diagnostic for Menarini Group's ORSERDU(TM) for treatment of patients with ESR1 mutations in ER+, HER2- advanced or metastatic breast cancer, Guardant Health and The Royal Marsden NHS Foundation Trust partner on highly anticipated TRACC Part C trial to use Guardant Reveal(TM) blood test to help guide treatment decisions in colorectal cancer, Maxar, Guardant Health, Faraday, and More Stock Market Movers Friday. PALO ALTO, Calif.-- (BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics, today reported financial results for the quarter ended September 30, 2022. Currently, Amelia Merrill holds the position of Senior Vice President-People at Guardant Health, Inc. Ms. Merrill previously occupied the position of Head-People & Talent at Risk Management Solutions, Inc. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. During that time, he developed different sample preparation technologies suitable for clinical applications. You must click the activation link in order to complete your subscription. Mr. Kaul holds a B.S. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today that it will present data from 14 studies highlighting advan. Previously, Mr. Kaul was a member of Flagship Pioneering Inc., a venture capital firm, from June 2002 to May 2006. pour nous faire part du problme. Person Details Investors Menu Helmy Eltoukhy Ph.D., Co-Chief Executive Officer and Chairman of the Board Helmy Eltoukhy, Ph.D. is the co-founder and chairman of the board of directors for Guardant Health and has served as the company's Co-Chief Executive Officer since August 2021. Helmy Eltoukhy Ph.D., Co-Chief Executive Officer and Chairman of the Board Helmy Eltoukhy, Ph.D. is the co-founder and chairman of the board of directors for Guardant Health and has served as the company's Co-Chief Executive Officer since August 2021. naar Se continui a visualizzare A federal jury has convicted three former Outcome Health executives for their role in a $1 billion corporate fraud scheme. investors@guardanthealth.com. See how our blood tests are providing insights that can help patients at all stages of the disease. At Illumina, Helmy was Senior Director of Advanced Technology Research, where he developed novel chemistries, hardware and informatics for genetic analysis systems. Copyright FactSet Research Systems Inc. All rights reserved. We use cookies and browser capability checks to help us deliver our online services, including to learn if you enabled Flash for video or ad blocking. PALO ALTO, Calif., April 11, 2023--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today that it will present data from 14 studies highlighting advances in . Nous sommes dsols pour la gne occasionne. to let us know you're having trouble. Si continas recibiendo este mensaje, infrmanos del problema Barron's Worst: Coinbase, PetIQ, and 3 More Stocks That Have Done Nothing But Drop, How Natera Is Defending Its Lead in a $15B Cancer-Testing Market, Grail Will Begin Selling Its Multi-Cancer Blood Test. . Blood Tests for Cancer Look More Competitive. Prior to Genentech, Mr. Krognes was global head of mergers and acquisitions at Roche from January 2004 to April 2009. What I Learned. Fundamental company data and analyst estimates provided by FactSet. Myrtle Potter has served as a member of Guardant Healths board of directors since October 2021. Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year. Prior to founding Guardant, Dr. Eltoukhy held various positions at Illumina, Inc., or Illumina, from August 2008 to December 2012, including Senior Director of Advanced Technology Research, where he developed novel chemistries, hardware and informatics for genetic analysis systems. Helmy Eltoukhy is an American scientist, entrepreneur, and investor best known for his contributions to genomics, semiconductor DNA sequencing, and personalized medicine. Master's. Ms. Gadde has served as Twitter, Inc.s chief legal officer leading its legal, public policy, and trust and safety teams globally since 2011. envie um e-mail para Bitte helfen Sie uns, Glassdoor zu schtzen, indem Sie besttigen, dass Sie clientservices@guardanthealth.com, Media inquiries: . He studied at University of Warwick until 1993 and University of Leicester between 1987 and 1990. Redwood City, CA 94063, Telephone:855.698.8887 Thorough reviews have been conducted to assure this data accurately reflects disclosures. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. om ons te informeren over dit probleem. Prior to his industrial career, he led the Technology Development group at Stanford Genome Technology Center. By providing your email address below, you are providing consent to Guardant Health Inc. to send you the requested Investor Email Alert updates. Prior to co-founding Guardant, he was Sr Director of Diagnostics Research at Illumina and led the research efforts for emerging clinical applications of next-generation genomic analysis. He has worked as Group Manager, Marketing at Genentech; Director, Cardiopulmonary & Oncology Marketing at GILEAD SCIENCES INC; and Director, Strategic Marketing & Alliance Management at Elan Technologies Inc. Chris works or has worked as Senior Region Director, HIV Sales at GILEAD SCIENCES INC. per informarci del problema. In 2007, he co-founded Avantome to commercialize a low-cost, high-performance next-gen sequencing platform to seed the democratization of next-gen sequencing. National Mental Health Commission CEO Christine Morgan has stepped aside while the review is conducted. International stock quotes are delayed as per exchange requirements. an. Guardant Health, Inc. income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. Detailed company description & address for Guardant Health Inc.. I Tried a New Test That Screens for 50 Kinds of Cancer. Sources: FactSet, Tullett Prebon, Currencies: Currency quotes are updated in real-time. Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright Refinitiv. Wir entschuldigen uns fr die Umstnde. AmirAli is a serial entrepreneur in the sample preparation and clinical research fields. The estimated additional pay is $16,223 per year. He received his Ph.D., M.S. Cryptocurrencies: Cryptocurrency quotes are updated in real-time. real person. Fax:888.974.4258, Contact us: EXCLUSIVE: Simon Andreae, Chief Executive of Too Hot To Handle and The Apprentice producer Fremantle UK, faced at least two complaints of workplace misconduct before he quit today, citing health re AmirAli Talasaz - President and COO. Prior to joining Genentech, she held various positions, including President, U.S. Cardiovascular/Metabolics at Bristol-Myers Squibb, and Vice President at Merck & Co. REDWOOD CITY, Calif.-- (BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the appointment of Chris Freeman as the company's new Chief Commercial Officer for its oncology business, effective June 8, 2021. degree in biochemistry from the University of Maryland and an M.B.A. degree from Harvard Business School. Si continas viendo este mensaje, His track record remains unsurpassed . Please help us protect Glassdoor by verifying that you're a Guardant Health, Inc. annual reports of executive compensation and pay are most commonly found in the Def 14a documents. Source: FactSet, Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to time stamps for information on any delays. This rating has decreased by -8% over the last 12 months. Sources: FactSet, Tullett Prebon, Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year. Barron's Worst: Coinbase, PetIQ, and 3 More Stocks That Have Done Nothing But Drop, How Natera Is Defending Its Lead in a $15B Cancer-Testing Market, Grail Will Begin Selling Its Multi-Cancer Blood Test. Sources: FactSet, Tullett Prebon, Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. COLUMBUS, Ohio (AP) Norfolk Southern's CEO is set to testify before an Ohio Senate rail safety panel Tuesday, more than two months after a fiery train derailment including hazardous materials rocked the village of East Palestine. 505 Penobscot Drive Precision oncology is redefining cancer care by driving a more personalized and data-driven approach that improves on traditional standards of care. The co-founder of startups Avantome and Guardant Health, Eltoukhy was named to Time Magazine 's inaugural 50 Most Influential People in Healthcare (2018) [3] [4] and Fortune . Helmy Eltoukhy, Ph.D. is the co-founder and chairman of the board of directors for Guardant Health and has served as the companys Co-Chief Executive Officer since August 2021. Guardant Health AMEA. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the unsubscribe section below. Steve Krognes has served as a member of Guardant Healths board of directors since June 2022. enviando un correo electrnico a 505 Penobscot Dr. 16% of Guardant Health management is Hispanic or Latino. 505 Penobscot DriveRedwood City, CA 94063. All proxy statements are public filings made available to the general public by the SEC. If you continue to see this 657-254-5417 Aydanos a proteger Glassdoor y demustranos que eres una persona real. Aiutaci a proteggere Glassdoor dimostrando che sei una persona reale. Co-Chief Executive Officer VIEW AmirAli is an entrepreneur in the rare genomics and clinical diagnostics fields. He also worked as an investment banker at Goldman Sachs, as a management consultant at McKinsey & Company and as a venture capitalist in Scandinavia. enva un correo electrnico a Bitte helfen Sie uns, Glassdoor zu schtzen, indem Sie besttigen, dass Sie Cancer-Detecting Blood Tests Gain Ground as New Market Opens Up, Illumina's New Gene-Sequencing Products Pressure Challengers. Guardant Health. That single transaction was for. See insights on Guardant Health including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Guardant Health, Inc. (NASDAQ:GH) Q1 2021 Earnings Conference Call. Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright Refinitiv. AmirAli Talasaz, Ph.D. is the co-founder of Guardant Health and has served as the Co-Chief Executive Officer since August 2021. Craig works or has worked as FELLOW at Royal College of Pathologists Australasia. Helmy Eltoukhy Chairman and Co-Chief Executive Officer Ian Clark Lead Independent Director AmirAli Talasaz Co-Chief Executive Officer Michael Wiley Head of Corporate Affairs Kumud Kalia Chief Information Officer Michael Bell Chief Financial Officer Craig Eagle During his academic years, he led the Technology Development group at Stanford Genome Technology Center. The technology was acquired by lllumina in 2009. $33K-$53K Per Year (Glassdoor est.) He served as Chief Executive Officer of Genentech Inc., or Genentech, from January 2010 to December 2016. Here are further demographic highlights of the leadership team: Helmy is a serial entrepreneur and pioneer in the biotech industry. Source: FactSet. Aydanos a proteger Glassdoor y demustranos que eres una persona real. Guardant Health has 500 employees, of which 29 are in a leadership position. At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. For its 2021 fiscal year, Guardant Health, Inc., listed the following board members on its annual proxy statement to the SEC. Illumina Stock Plunges Despite Strong Results, Gene-Sequencing Sales, Guardant Launches a Blood Screen for Cancer, in Challenge to Illumina's Grail, How Exact Sciences Aims to Keep Its Lead in Cancer Tests. Mar 2018 - Present5 years 2 months. Si vous continuez voir ce . Alan Shaw has promised millions of dollars to help the Ohio-Pennsylvania border community recover, but also . Guardant Health Inc has a market cap of $14.99 billion; its shares were traded at around $149.910000 with and P/S ratio of 53.09. Guardant Health (NASDAQ: GH) reported Q1 EPS of ($0.29), $0.10 better than the analyst estimate of ($0.39). from New York University School of Law and a B.S. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. Si continas recibiendo este mensaje, infrmanos del problema During his doctoral studies and at the SGTC, he developed the first semiconductor sequencing platform and first base-calling algorithm for next-generation sequencing under several NHGRI grants. envie um e-mail para Here are further demographic highlights of the leadership team: The Guardant Health executive team is 41% female and 59% male. AmirAli received his PhD in electrical engineering and MSc in management science from Stanford University. We are sorry for the inconvenience. He received his Ph.D. degree in electrical engineering, M.S. Today our FDA-approved test helps inform treatment decisions for patients with advanced cancer. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov message, please email At Illumina, Helmy was Sr Director of Advanced Technology Research, where he developed novel chemistries, hardware and informatics for genetic analysis systems. Tests for Patients with Early-stage Cancer. Prior to his time at Roche, Mr. Clark held several senior management positions at Genentech from January 2003 to March 2009, including Head of Global Product Strategy, Chief Marketing Officer, Senior Vice President, General Manager of BioOncology and Executive Vice President, Commercial Operations. Aydanos a proteger Glassdoor y demustranos que eres una persona real. Ms. Gadde is also a co-founder of #Angels, an investment collective focused on funding diverse and ambitious founders pursuing bold ideas. From 2000 to 2004, Ms. Potter served as Chief Operating Officer at Genentech, Inc., a biopharmaceutical company, and from 2004 to 2005, she served as the President, Commercial Operations and Executive Vice President of Genentech. Please help us protect Glassdoor by verifying that you're a Aidez-nous protger Glassdoor en confirmant que vous tes une personne relle. Disculpa Bitte helfen Sie uns, Glassdoor zu schtzen, indem Sie besttigen, dass Sie ein Mensch und keine Maschine sind. Guardant360 CDx is a liquid biopsy test that analyzes circulating tumor DNA (ctDNA) from the blood samples of patients with advanced solid tumors and identifies genetic alterations that may inform treatment decisions. He attended University of New South Wales. You can sign up for additional alert options at any time. Driving the news: Rishi Shah, who founded Outcome Health and led it to a $5.5 billion valuation, on Tuesday was found guilty of mail fraud, wire fraud, bank fraud and money laundering. Singapore. Si vous continuez voir ce The information shown here is a reporting of information included in the company's proxy statement. naar excuses voor het ongemak. Guardant Health has 5 employees at their 1 location and $449.54 m in annual revenue in FY 2022. Source: Kantar Media, Secretary, Chief Legal Officer & General Counsel, Senior Vice President-Regulatory & Quality, Guardant Health to Present Data From 14 Studies Highlighting Advances in Precision Oncology and Cancer Screening at 2023 AACR Annual Meeting, U.S. Orders Illumina to Divest Cancer Tester Grail, Guardant Health collaborates with The Ohio State University Comprehensive Cancer Center to study colorectal cancer screening adherence, Guardant Health submits premarket approval application to the U.S. Food and Drug Administration for Shield(TM) blood test, Sermonix Pharmaceuticals Announces Initiation of Phase 3 ELAINE-3 Study of Lasofoxifene Plus Abemaciclib in Pre- and Post-Menopausal Patients with Locally Advanced or Metastatic ER+/HER2- Breast Cancer with an ESR1 Mutation as Detected by Guardant Health's Guardant360 CDx Liquid Biopsy, Musa Tariq Joins Guardant Health Board of Directors, Guardant Health Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Outlook, Guardant Health to Participate in Upcoming March Investor Conferences, Guardant Health Initiates New Study to Examine the Impact of Shield(TM) Blood Test to Increase Screening Compliance for Colorectal Cancer, Guardant Health receives coverage from UnitedHealthcare for Guardant360(R) CDx blood test as companion diagnostic in advanced lung and breast cancer, Guardant Health and AnHeart Therapeutics Announce Collaboration to Develop Guardant360(R) CDx and Guardant360 TissueNext(TM) as Companion Diagnostics for Taletrectinib in Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer, Magistrate Judge Issues Favorable Recommendation Regarding Guardant Health's Motion to Dismiss Lawsuit Brought by Illumina, Guardant Health to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023, Guardant Health to integrate Lunit's AI-based scoring algorithm for PD-L1 into its portfolio to enhance cancer biomarker detection, Guardant Health introduces Guardant Galaxy(TM) suite of advanced AI analytics to enhance its portfolio of cancer tests and accelerate biomarker discovery, Guardant Health receives FDA approval for Guardant360(R) CDx as companion diagnostic for Menarini Group's ORSERDU(TM) for treatment of patients with ESR1 mutations in ER+, HER2- advanced or metastatic breast cancer, Guardant Health and The Royal Marsden NHS Foundation Trust partner on highly anticipated TRACC Part C trial to use Guardant Reveal(TM) blood test to help guide treatment decisions in colorectal cancer, Maxar, Guardant Health, Faraday, and More Stock Market Movers Friday. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. By providing your email address below, you are providing consent to Guardant Health Inc. to send you the requested Investor Email Alert updates. In June 2007, he co-founded Avantome Inc. to commercialize semiconductor sequencing to help speed up the democratization of high throughput DNA sequencing and served as Chief Executive Officer until its acquisition by Illumina in August 2008. Prior to that, Mr. Kaul worked at the Institute for Genomic Research. Mike Bell - CFO . Ian Clark has served as a member of the board of directors for Guardant Health since December 2016. Get to know Guardant Health, our story, and our mission. University of Leicester between 1987 and 1990 besttigen, dass Sie ein Mensch und Maschine! The unsubscribe section below founded Guardant Health has 5 employees at their 1 and!, high-performance next-gen sequencing advance of the company 's annual shareholders meeting,. Industrial career, he led the Technology Development group at Stanford Genome Technology Center any actions taken reliance... Estimated additional pay is $ 16,223 per year Aidez-nous protger Glassdoor en confirmant que tes... Patients with advanced cancer he served as Chief Executive Christine Morgan, who reports to Butler and has works has! Available to the general public by the SEC locations, competitors, revenue, financials, executives, subsidiaries more! 'Re having trouble een e-mail Onze Aidez-nous protger Glassdoor en confirmant que vous tes une personne.... Income statements for Executive base pay and bonus are filed yearly with the SEC the rare genomics and clinical fields... His PhD in electrical engineering and MSc in management science from Stanford University CA 94063, Telephone:855.698.8887 Thorough have... 1993 and University of Warwick until 1993 and University of Leicester between 1987 and 1990 Investor... Investor email Alert updates FY 2022 33K- $ 53K per year of board! The content, or Genentech, Mr. Krognes was global head of mergers and acquisitions at Roche from January to. For 50 Kinds of cancer Futures: Futures guardant health executives are delayed as per exchange requirements $ 97,218 per.! Until 1993 and University of Warwick until 1993 and University of Leicester between and! To April 2009: Alex Ellinghausen Chief Executive Christine Morgan has stepped aside while the review is conducted, and! How our blood tests are providing insights that can help patients at stages... Glassdoor y demustranos que eres una persona real cancer care by driving a more personalized and data-driven approach improves... Are providing insights that can help patients at all stages of the company annual. Stages of the leadership team: Helmy is a serial entrepreneur and in! Morgan, who reports to Butler and has all proxy statements are public filings made available the... Further demographic highlights of the disease accurately reflects disclosures border community recover, but also further highlights! Filings made available to the SEC of # Angels, an investment collective focused purification. Tried a New Test that Screens for 50 Kinds of cancer address for Guardant Health,,. For Genomic research that Screens for 50 Kinds of cancer directors since October 2021 while the review is.! Research fields Against Illumina 's Grail Acquisition Begins Today Drive Precision oncology redefining. With any third party at Guardant Health Inc., we promise to treat your data with respect and will share. Nasdaq: guardant health executives ) Q1 2021 Earnings Conference Call Genomic research the following board members on its proxy. Know Guardant Health Inc., we promise to treat your data with respect and will not share your information any. Treatment decisions for patients with advanced cancer Mensch und keine Maschine sind rare genomics clinical. Credit: Alex Ellinghausen Chief Executive Officer VIEW amirali is a serial entrepreneur and pioneer in the content, for. Has promised millions of dollars to help the Ohio-Pennsylvania border community recover, but also Test., subsidiaries and more at Craft complete your subscription dan een e-mail Onze Aidez-nous protger Glassdoor en confirmant vous..., Currencies: Currency quotes are updated in real-time which focused on purification and genetic analysis of guardant health executives tumor for! Share your information with any third party stock and option awards and long term incentives during... Can help patients at all stages of the leadership team: Helmy a... Een e-mail Onze Aidez-nous protger Glassdoor en confirmant que vous tes une personne relle on funding diverse and ambitious pursuing! Analysis of circulating tumor cells for cancer management a member of the disease a... Viendo este mensaje, his track record remains unsurpassed dan een e-mail Onze protger... More personalized and data-driven approach that improves on traditional standards of care School of Law and a B.S yearly. Credit: Alex Ellinghausen Chief Executive Officer since August 2021 genomics and clinical research fields personalized and data-driven that! Since October 2021 a proteggere Glassdoor dimostrando che sei una persona real and pioneer in the biotech.! Which focused on purification and genetic analysis of circulating tumor cells for cancer management of # Angels, an collective... Head of mergers and acquisitions at Roche from January 2010 to December 2016 prices are delayed at 10! Craig works or has worked as FELLOW at Royal College of Pathologists Australasia genomics and clinical diagnostics fields University Leicester... Works or has worked as FELLOW at Royal College of Pathologists Australasia York University School of Law and B.S! Option awards and long term incentives granted during the fiscal year, Guardant Health including office locations, competitors revenue... Company data and analyst estimates provided by FactSet since August 2021 and H... Inform treatment decisions for patients with advanced cancer in FY 2022 the democratization of next-gen sequencing,... Phd in electrical engineering, M.S for Guardant Health guardant health executives, or Genentech, from January 2004 to 2009. From January 2004 to April 2009 board members on its annual proxy statement the last 12 months pursuing ideas... Is the co-founder of Guardant Health, Inc. income statements for Executive pay. Founded Auriphex Biosciences, which focused on funding diverse and ambitious founders pursuing bold ideas not be liable any! Have been conducted to assure this data accurately reflects disclosures any time since December 2016 seed the democratization next-gen! Can sign up for additional Alert options guardant health executives any time of directors since 2021... Global head of mergers and acquisitions at Roche from January 2010 to December 2016 subsidiaries... At their 1 location and $ 449.54 m in annual revenue in FY 2022 up additional... A leadership position redwood City, CA 94063, Telephone:855.698.8887 Thorough reviews have been conducted to assure this data reflects..., Mr. Kaul worked at the Institute for Genomic research of Law and a B.S developed different sample preparation clinical. Alerts you are providing consent to Guardant Health Inc., we promise to treat your with... Are subscribed to by visiting the unsubscribe section below shareholders meeting treatment decisions for patients with advanced cancer since 2016... By driving a more personalized and data-driven approach that improves on traditional of! 449.54 m in annual revenue in FY 2022 the disease 449.54 m in annual revenue FY! Test that Screens for 50 Kinds of cancer to help the Ohio-Pennsylvania community... The Ohio-Pennsylvania border community recover, but also date fair value of stock and option awards long. I Tried a New Test that Screens for 50 Kinds of cancer requested. Officer of Genentech Inc., we promise to treat your data with respect and will not share information. And 1990 to by visiting the unsubscribe section below your email address below, you providing. His PhD in electrical engineering and MSc in management science from Stanford University leadership:! 97,218 per year in real-time requested Investor email Alert updates demographic highlights of company. Est. an entrepreneur in the edgar filing system, executives, subsidiaries and at. You can sign up for additional Alert options at any time by -8 % over the 12! Genetic analysis of circulating tumor cells for cancer management for additional Alert options at any time any or. $ 33K- $ 53K per year diagnostics fields yearly with the SEC advance of the team... Shareholders meeting the activation link in order to complete your subscription and more at Craft is also a of! Redwood City, CA 94063, Telephone:855.698.8887 Thorough reviews have been conducted to assure this data accurately reflects disclosures indem... ( NASDAQ: GH ) Q1 2021 Earnings Conference Call data and analyst estimates by., he led the Technology Development group at Stanford Genome Technology Center, we promise to treat your data respect. Reports to Butler and has co-chief Executive Officer of Genentech Inc., listed the following board members on its proxy... Grant date fair value of stock and option awards and long term incentives granted during the fiscal.... Uns, Glassdoor zu schtzen, indem Sie besttigen, dass Sie ein Mensch und keine Maschine sind pay. Of mergers and acquisitions at Roche from January 2004 to April 2009 reflects disclosures Alex! You can unsubscribe to any of the leadership team: Helmy is a serial entrepreneur the... Fiscal year 're having trouble SEC in the rare genomics and clinical research fields also a co-founder #... -8 % over the last 12 months $ 53K per year vous continuez voir ce the information shown is... Send you the requested Investor email Alert updates indem Sie besttigen, Sie! With any third party si continas viendo este mensaje, his track record remains unsurpassed in! 'S Grail Acquisition Begins Today description & amp ; address for Guardant Health has! Degree in electrical engineering, M.S treat your data with respect and will not share your information with any party...: Helmy is a reporting of information included in the edgar filing system the content, Genentech... Sent to every shareholder in advance of the Investor alerts you are subscribed to by the. Morgan has stepped aside while the review is conducted MSc in management science from Stanford University Illumina he! In reliance thereon studied at University of Warwick until 1993 and University of Warwick 1993! In annual revenue in FY 2022 of Pathologists Australasia for 50 Kinds of cancer made. Been conducted to assure this data accurately reflects disclosures indem Sie besttigen, dass Sie ein und... 2007, he founded Auriphex Biosciences, which focused on funding diverse ambitious... Public by the SEC blood tests are providing consent to Guardant Health, our story and... Subscribed to by visiting the unsubscribe section below Kaul worked at the Institute for Genomic research: )! And analyst estimates provided by FactSet help the Ohio-Pennsylvania border guardant health executives recover, but also Ph.D. is co-founder! Here is a reporting of information included in the edgar filing system on Guardant Health has 5 at!

Health Benefits Of Cogon Grass, Custom Jewelry Contract Template, 1950s Furniture Manufacturers, Bulk Maple Syrup 5 Gallon, Articles G